Showing results (321-330 of 346) with videos related to
Sort By:
Pageof 35
Journal of the American Chemical Society|April 24, 2026
Transformation of CeO<sub>2</sub> Nanoparticles into Atomically Dispersed Ce Cations Leads to Enhanced Reactivity for Automotive Emissions ControlDong Jiang, Hien N Pham, Yixiao Li, et al.Blood|March 3, 2026
Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphomaJennifer L Crombie, Sairah Ahmed, Matthew J Frigault, et al.Journal for Immunotherapy of Cancer|April 5, 2025
Conformation-sensitive targeting of CD18 depletes M2-like tumor-associated macrophages resulting in inhibition of solid tumor progressionIk-Hwan Han, Ilseob Choi, Hongseo Choi, et al.Blood Advances|July 24, 2025
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysisNausheen Ahmed, Swetha Thiruvengadam, Mehdi Hamadani, et al.Transplantation and Cellular Therapy|September 29, 2021
Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic SyndromeAnurag Singh, Christopher E Dandoy, Min Chen, et al.British Journal of Haematology|June 14, 2021
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantationCarolyn M Mulroney, Muhammad Bilal Abid, Asad Bashey, et al.Blood|March 3, 2021
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysisScott R Goldsmith, Muhammad Bilal Abid, Jeffery J Auletta, et al.Blood Advances|September 1, 2019
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1Celalettin Ustun, Soyoung Kim, Min Chen, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 14, 2019
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR studySeema Naik, Marcie Riches, Parameswaran Hari, et al.Bone Marrow Transplantation|December 15, 2018
Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantationCelalettin Ustun, Jo-Anne H Young, Genovefa A Papanicolaou, et al.Pageof 35